
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3974 Introduced in Senate (IS)]








117th CONGRESS
  2d Session
                                S. 3974

To prohibit the consideration of patients' race, color, religion, sex, 
 national origin, age, disability, vaccination status, veteran status, 
    or political ideology or speech in determining eligibility for 
    monoclonal antibody doses distributed by the Federal Government.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             March 31, 2022

   Mr. Cruz introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
To prohibit the consideration of patients' race, color, religion, sex, 
 national origin, age, disability, vaccination status, veteran status, 
    or political ideology or speech in determining eligibility for 
    monoclonal antibody doses distributed by the Federal Government.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ending Discrimination in COVID-19 
Treatments Act''.

SEC. 2. ELIGIBILITY TO RECEIVE MONOCLONAL ANTIBODY TREATMENT.

    The Secretary of Health and Human Services shall require States, as 
a condition for receipt of monoclonal antibody doses from the Federal 
Government, to ensure that providers receiving distributions of such 
monoclonal antibody doses from such States do not take into 
consideration the race, color, religion, sex, national origin, age, 
disability, vaccination status, veteran status, or political ideology 
or speech of a patient in determining whether a patient is eligible to 
receive such treatment.
                                 
